Results 101 to 110 of about 1,032 (154)

[C-reactive protein, cardiovascular issues of an acute-phase protein: an update for theclinician]. [PDF]

Arch Cardiol Mex
Sáenz-San Martín A, Méndez-Ocampo P, Gutiérrez-Moctezuma I, Amezcua-Guerra LM.   +3 more
europepmc   +1 more source

[Report of 3 cases of acute hemorrhagic leukoencephalitis in Mexico]. [PDF]

Rev Med Inst Mex Seguro Soc
Aguilar-Vázquez CA, Reyes-Hernández CC, Hernández-Domínguez JA, Raymundo-Carrillo AD, Flores-Vivaldo ED.   +4 more
europepmc   +1 more source

Mechanical ventilation, hospitalization time, deaths and disability according to the variants of Guillain-Barré syndrome: systematic review and meta-analysis. [PDF]

Rev Peru Med Exp Salud Publica
Castro Diaz SX, Pereira-Salto L, Araujo Castillo RV.   +2 more
europepmc   +1 more source

[XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (II)]. [PDF]

Rev Neurol
Fernández Ó, Arés A, Agüera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Caminero AB, Castillo-Triviño T, Costa-Frossard L, Eichau S, Hernández MÁ, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Moral E, Oreja-Guevara C, Prieto JM, Romero-Pinel L, Vilaseca A, Rodríguez-Antigüedad A.   +23 more
europepmc   +1 more source

[Drug Excipients. Necessary, but not Harmless]. [PDF]

Farm Comunitarios
López Alarcón MD, Justo Hernández A, Santos Cruz P.   +2 more
europepmc   +1 more source

Debate: ECMO in patients with cardiogenic shock due to myocardial infarction. A clinician's perspective. [PDF]

REC Interv Cardiol
Rosillo Rodríguez SO.
europepmc   +1 more source

[Dyslipidemia in high cardiovascular risk patients. Initial results from the REMEXDIS-IMSS study]. [PDF]

Rev Med Inst Mex Seguro Soc
Machuca-Loeza MG, Fernández-Hernández JP, Gutiérrez-Galván MX, Borrayo-Sánchez G, Cruz-Aceves I, Solorio-Meza SE, Hernández-González MA.   +6 more
europepmc   +1 more source

[Clinical characterization of patients with complete fetal atrioventricular block]. [PDF]

Arch Cardiol Mex
Muralles-Castillo FA.
europepmc   +1 more source

Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country [PDF]

Biomedica
Panesso GA, Martínez JD, Velasco A, Forero S, Perdomo D, Villamil Á, González ER, Jiménez CA.   +7 more
europepmc   +1 more source

[Anticoagulation instauration in device-detected subclinical atrial fibrillation: what impact does it have on outcomes?] [PDF]

Arch Peru Cardiol Cir Cardiovasc
Fuentes Blanco HF, Malagón Albarracín DA, González Perdomo FJ, Ortega Sierra M.   +3 more
europepmc   +1 more source